Author

Jonathan Blake

Jonathan Blake contributes analysis and perspective on structural and strategic shifts across the biotechnology and healthcare landscape. His writing explores how innovation ecosystems evolve, how incentives shape outcomes, and where emerging tensions may redefine the industry. At BioIntel, Jonathan provides context-driven insight that complements reporting with deeper reflection.

20 articles

Jonathan Blake

Recent posts

Coral Care's $13 Million Funding Boost to Expand In-Home Pediatric Therapy Services

Sickle Cell Gene Therapies Casgevy and Lyfgenia Face Market Challenges Two Years Post-Approval

Redefining Obesity Treatment: Innovations Beyond GLP-1 Limitations

Korsana Biosciences Breaks New Ground in Alzheimer’s Research With $150M Funding and Next-Gen Antibody

Ocular Therapeutix's Axpaxli Surpasses Regeneron’s Eylea in Phase 3 Trial for Wet AMD

Bayer Agrees to $7.25 Billion Settlement Over Roundup Cancer Lawsuits

Vertex and CRISPR Set Ambitious Goals for Casgevy Gene Therapy Amid Growing Patient Access

Sanofi Announces Change in Leadership as Paul Hudson Steps Down as CEO

Controversy in Biopharma: Hims & Hers’ Compounded Wegovy Pill Sparks Industry Backlash

TrumpRx Launch: Examining the New Prescription Drug Platform and Its Market Impact

Why Women’s Health Emerges as a Scalable Sector in Today’s Healthcare Landscape

Sanofi Advances Treatment for Neurological Symptoms in Rare Disease with Experimental Drug